September 2026
- Adie Tonic Pupil
- The Long Shadow of Bedlam
- AI-Based Translation of Discharge Instructions — Aligning Policy with Practice
- The Future of the USPSTF and Evidence-Based Recommendations
- When Fear Became the Barrier to Care — Lessons of a Clinical Rapid Response during Operation Metro Surge
- Urticarial Vasculitis
- Break a Leg
- Fluid Resuscitation in Patients with Sepsis — For Whom the Balance Tolls
- Infigratinib in Achondroplasia — A Potentially Giant Step Forward
- Hypomethylating Agents plus Venetoclax as Compared with Intensive Chemotherapy in Patients with AML
- Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
- A Zoonotic Orthonairovirus from Febrile Patients in China
- Childhood Vaccine Hesitancy
- More on Causes of Death among Children and Adolescents in the United States
- Telitacicept for IgA Nephropathy
- Acro-Osteolysis
- Physical Examination for Asymptomatic Adults
- Case 20-2026: A 38-Year-Old Man with Abdominal Pain
- Daraxonrasib for Previously Treated RAS-Mutant Non–Small-Cell Lung Cancer
- Pulmonary Nodules
- Azacitidine–Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia
- Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism
- Immediate Ambulatory Electrocardiographic Monitoring in Syncope
- Tricuspid-Valve Intervention in Heart Failure
- Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation
- Pulmonary Denervation for Heart Failure–Related Pulmonary Hypertension
- Telehealth Access to Mifepristone — Evaluating Reproductive-Coercion Arguments
- Maximizing Legal Care under Bans on Abortion Provision — A Framework for Reclaiming Agency
- Safe Space
- Scrofuloderma
- Human–Animal Bonds as Social Determinants of Health Care Access
- Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients
- Prasugrel versus Ticagrelor in Acute Coronary Syndromes
- The Emerging Role of Treatment Policy Implementation Trials in Acute Coronary Syndrome
- Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI
- Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event
- Prevalence of Silent Atherosclerosis across Adult Life
- Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults
- Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain
- Complete Revascularization Guided by Functional Coronary Angiography in STEMI
- Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
- Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis
- Anticoagulation for Atrial Fibrillation with a Single Risk Factor for Stroke
- Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
- Eplontersen for Transthyretin Amyloid Cardiomyopathy
- Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310
- Phase 3 Trial of Weekly Oral Islatravir–Lenacapavir for HIV-1 Treatment
- Andes Virus — A Clinical Review
- Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty
- Retraction: Jayne DRW et al. Avacopan for the Treatment of ANCA-Associated Vasculitis, N Engl J Med 2021;384:599-609.